Clinical trial underway for treatment of sleep apnea in adolescents with Down syndrome

(Massachusetts Eye and Ear Infirmary) An FDA-approved clinical trial is underway at Massachusetts Eye and Ear and Massachusetts General Hospital for Children to evaluate the use of a hypoglossal nerve stimulator -- a technology currently available to adults with severe obstructive sleep apnea (OSA) that stimulates the upper airway to facilitate breathing during sleep -- in a select group of adolescent patients with Down syndrome and OSA.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news